From: Long-term visual outcomes of endophthalmitis and the role of systemic steroids in addition to intravitreal dexamethasone
No steroids
Systemic steroids
Age (years)
72.7
69.3
%
Male
28.4
68.8
Female
71.6
31.3
Diabetic
18
25
Average follow up (days)
477
449